Melanoma vaccine (Ichor Medical Systems/Memorial Sloan-Kettering Cancer Center)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMelanoma vaccine (Ichor Medical Systems/Memorial Sloan-Kettering Cancer Center)
Drug Alias NamepINGmuTyrXenogeneic tyrosinase DNA vaccineMouse tyrosinase plasmid DNA vaccine
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUveal melanomaSkin Melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterIchor Medical Systems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer CenterIchor Medical Systems Inc
Active IndicationsN/A
Inactive IndicationsUveal melanomaSkin Melanoma

Other Information

ATC CodeN/A
Related LinksN/A